Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TARGET study: Azithromycin to reduce asthma exacerbations in overweight/obese adults
jRCTs071220023Recruiting
- Sponsor
- Ministry of Education, Culture, Sports, Science and Technology
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of azithromycin in asthma, sponsored by Ministry of Education, Culture, Sports, Science and Technology. Primary endpoint: Primary endpoint: change in asthma exacerbation rate. Started Jun 2022; status: recruiting.
02
Drugs
azithromycin
03
Conditions
asthma
Beyond the preview
Go deeper on jRCTs071220023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071220023.